Bär & Karrer Advised NORD Holding and
1Q Health Group on the Acquisition of
Gelpell AG

Funds advised by NORD Holding and its portfolio company 1Q Health Group have acquired Gelpell AG, a Swiss specialist in the development and contract manufacturing of softgel, hard and vegetarian capsules. Gelpell provides product development, contract manufacturing and regulatory support services and has particular expertise in softgel technology, including its patented GELPELL Beads technology.

1Q Health Group is a leading European CDMO and development partner for pharmaceuticals and dietary supplements. NORD Holding is a private equity and asset management company with approximately EUR 4 billion in assets under management.

Bär & Karrer acted as Swiss legal advisor to the funds advised by NORD Holding and its portfolio company 1Q Health Group in connection with the transaction. The Bär & Karrer team was led by Philippe Seiler and included Nick Aschwanden and Dennis Loki (both M&A), Faton Aliu, Dominique Simmen and Steven Gscheider (all Financing), Laura Widmer and Luljeta Morina (both Employment), Rocco Rigozzi and Corina Moschen (both Real Estate), Markus Wang and Christine Schweikard (both IP/IT), as well as Martin Werner (Competition).